Search Results 351-360 of 16361 for anti-TNF drugs

1. A Study To Assess The Efficacy And Safety Of Induction And Maintenance Therapy With Afimkibart (RO7790121) In Participants With Moderately To Severely Active Crohn's Disease - Mayo Clinic

   ... drugs, surgical procedures or devices. ... * Has received protocol-specified prohibited medicines, including known exposure to any type of anti-TL1A therapy.

2. Lymphoma Clinical Trials - Mayo Clinic Research

   Rituximab, an anti-CD20 chimeric antibody, was approved by the United States Food and Drug Administration in 1998 for the treatment of patients with relapsed ...

3. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   About this study. This phase II trial tests how well nivolumab in combination with chemotherapy drugs along with radiation therapy works in treating ...

4. Drug Combo Shuts Down Stem Cells, Tumor Growth in Lung Cancer - Mayo Clinic News Network

   The combination therapy worked in a laboratory study to stop lung adenocarcinoma associated with mutation of the KRAS gene. The study will be published in the ...

5. Sulfamethoxazole and trimethoprim (oral route) - Side effects & dosage - Mayo Clinic

   Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

6. A Study to Evaluate the Immune Response to Anti-HER2 Therapies - Mayo Clinic

   Scheded to start new anti=HER2 therapy/therapies. Provide written informed consent. Willingness to provide blood samples for correlative research purposes ...

7. Trazodone (oral route) - Side effects & dosage - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

   Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

9. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... For any other TNF-α antagonist, the participant ... Has had previous exposure to approved or investigational ...

10. Cellular Therapy Clinical Trials - Mayo Clinic Research

    ... anti-Crohn's therapy. Six weeks post placement of the draining seton, the seton will be replaced with the MSC loaded Gore® Bio-A® fistula plug as per ...